Simulations Plus Provides Additional Details Regarding Cognigen Corporation Acquisition

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today provided additional details regarding its Agreement and Plan of Merger (the “Agreement”) with Cognigen Corporation (“Cognigen”) of Buffalo, New York, announced yesterday.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC